Ojjaara

momelotinib

Approval

ApplicationNDA 216873
Approval dateSep 15, 2023
Approval year2023
SponsorGlaxosmithkline

FDA-approved use

To treat intermediate or high-risk myelofibrosis in adults with anemia

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Ojjaara: